Tackle Prostate Cancer with the Philadelphia Eagles and Jefferson

PE-banner-300x250This year, Jefferson will be the presenting sponsor at the Eagle’s home opening game on September 7th against the Jacksonville Jaguars.

Visit the Jefferson tent to register for our raffle to win Eagles tickets, autographed memorabilia, and an Eagles prize pack. You can also pick up Jefferson sunglasses, sunscreens, and chapsticks and learn more about prostate cancer and screenings.

Prostate cancer is the most common type of solid tumor cancer among men with some 220,000 new cases diagnosed each year.

So guys, if you’re over 50 years of age, have a family history of prostate cancer or are at greater than normal risk of prostate cancer, such as African American men, you should talk to a physician about whether having a prostate cancer screening is right for you.

Jefferson’s Department of Urology is one of the oldest in the United States, with internationally recognized experts in all major fields of urology, including prostate health. Jefferson earned a top ranking in Urology for 2014-15 from U.S. News and World Report.

In addition to the game, this September the Sidney Kimmel Cancer Center at Thomas Jefferson University and Prostate Health International’s Gary Papa Run will be offering free prostate health screenings as part of a research program. Screening is important because prostate cancer shows no symptoms in its earliest stages.

Free screenings will take place on:

  • Wednesday, September 17, 2014, 9 a.m. to 3 p.m., at the Sidney Kimmel Cancer Center – Bodine Building, 111 S. 11th Street, Center City
  • Friday, October 3rd, 2014, 9 a.m. to 3 p.m., at Jefferson at the Navy Yard – 3 Crescent Drive, Suite 100, South Philadelphia

To register for the men’s health event with free prostate health assessment, or for more information, call 1-800-JEFF-NOW (800-533-3669).


, , , ,

No comments yet.

Add Your Comments and Join the Conversation

Comments are moderated and generally will be posted if they are on-topic and not abusive.
View our commenting policy.